PPT-Medicines About the team

Claire Vaughan Head of Meds Optimisation Lindsay Harper Director of Pharmacy SRFT Jim Corcoran Clinical Director for Theatres SRFT Karen Proctor Director of Commissioning Liz Walton Designated . Use of counterfeit medicines can result in treatment failure or even death Public confidence in healthdelivery syst ems may be eroded following use andor detection of counterfeit medicines Both branded and generic products are subj ect to counterfei Programme. General overview and . update. Dr Milan . Smid. WHO Prequalification of Medicines Programme. Amman, June 2013. UN Prequalification . Programme. . for Priority Essential Medicines. Action plan of UN from 2001 for expanding access to selected priority medicines . Healing Our Relationships to the Land Through Intergenerational Mentorship. I am standing. In a sacred way. At the earth’s center. Beheld by the people,. Seeing the tribe. Gathered around me. - John Fire . Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. People use medicine to restore their body to optimal health.. Medicines are drugs that are used to treat or prevent disease or other conditions. . Drugs are substances other than food that change the structure or function of the body or mind. . Cochin University of Science & Technology . Sakthivel. . Selvaraj. Public Health Foundation of India . New . Delhi . (shakti@phfi.org). Access to Medicines in India . Key Barriers to . Access to Medicines . for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Programme. General overview and . update. Dr Milan . Smid. WHO Prequalification of Medicines Programme. Amman, June 2013. UN Prequalification . Programme. . for Priority Essential Medicines. Action plan of UN from 2001 for expanding access to selected priority medicines . Definition: substances that, when taken internally or applied to the body, help prevent or cure a disease or other medical problem. Classifications. Prevent disease. Fight pathogens . (microorganisms that enter the body and attack its cells and tissues). By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. Herbal preparations . could . be regarded as the original biologic approach to medicine.. Herbal medicines can be applied to the treatment of a variety of ailments, . including both . acute and chronic . NOT. regulated by EU legislation and no uniform definition is available.. Off-label use of a medicine is the use of an authorised medicine by a healthcare professional to treat a patient in a way not covered by Marketing Authorisation (MA) and detailed in the Summary of Product Characteristics (. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda.